EMIKO HIRAOKA

Last Updated :2024/07/03

Affiliations, Positions
Hiroshima University Hospital(Medical), Assistant Professor
E-mail
hiraoka7hiroshima-u.ac.jp
Self-introduction
I am working extensively on breast cancer diagnosis, surgery, drug therapy, clinical trials, hereditary breast cancer, cancer genome medicine, etc. In addition, I am conducting basic research to elucidate the mechanism of invasive metastasis from breast cancer cell motility.

Basic Information

Educational Backgrounds

  • Yamaguchi University School of Medicine, Japan, 2001/04, 2007/03/20
  • Hiroshima University Graduate School of Medicine, Graduate School of Biomedical & Health Sciences, Japan, 2012/04/01, 2019/05/23

Academic Degrees

  • Hiroshima University

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Research Keywords

  • Breast cancer cell motility, Invasion, Metastasis

Affiliated Academic Societies

  • Japan Surgical Society Japanese Breast Cancer Society Japan Esophageal Society The Japanese Association for Chest Surgery Japanese Society of Medical Oncology The Japan Society of Clinical Oncology The Japanese Society for Hereditary Tumors Japanese Society of Genetic Counseling

Research Activities

Academic Papers

  1. ★, Breast cancer cell motility is promoted by 14-3-3 gamma., Breast Cancer, 26(5), 581-593, 20190304
  2. ★, Follicular lymphoma without lymphadenopathy incidentally diagnosed by sentinel lymph node biopsy during breast cancer surgery: a case report. surg case rep: 8, 167, 2022., Surgical Case Reports, 8(1), 167, 20220913

Invited Lecture, Oral Presentation, Poster Presentation

  1. Linking the companion diagnostic function of cancer genome profiling to therapy - Investigation of TMB-high predictors (e13033), Emiko Hiraoka, Akiko Emi, Hikaru Nakahara, Asuka Toshida, Kanako Suzuki, Mutsumi Fujimoto, Haruka Ikejiri, Ai Amioka, Shinsuke Sasada, Mihoko Doi, Taizo Hirata,Tomoyuki Yoshiyama, Ichiko Yamakita, Yuki Kaneko, Tomoko Itagaki, Keiko Kajitani, Hideo Shigematsu, Takao Hinoi, Morihito Okada, The 2024 ASCO Annual Meeting, 2024/05/31, Without Invitation, English, American Society of Clinical Oncology (ASCO), Chicago, USA

External Funds

Acceptance Results of Competitive Funds

  1. Young Researchers in 2023